Central Serous Chorioretinopathy

Excerpt

Central serous chorioretinopathy (CSCR) is a retinal disorder characterized by localized serous detachment of the macula with or without focal serous pigment epithelial detachment (PED). It is mostly seen in young men aged 20–45 years. Albert V Graefe first described this condition as central recurrent retinitis in 1866. Bennet coined the term “central serous retinopathy,” and Gass described the pathogenesis. The patient complains of distorted images, the apparent small size of objects, and blurred vision. Most of the cases resolve spontaneously in 3-6 months. For non-resolving cases, treatment includes laser photocoagulation and photodynamic therapy. AntiVEGF and mineralocorticoid receptor antagonists have also been tried.